{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:32:57Z","timestamp":1793413977042,"version":"4.5.0"},"reference-count":54,"publisher":"American Society of Hematology","issue":"25","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,6,22]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>Ph-like ALL is characterized by a diverse array of genetic alterations activating cytokine receptor and tyrosine kinase signaling. Pediatric patients with Ph-like ALL can be identified in real time for effective treatment stratification.<\/jats:p>","DOI":"10.1182\/blood-2016-12-758979","type":"journal-article","created":{"date-parts":[[2017,4,13]],"date-time":"2017-04-13T21:10:34Z","timestamp":1492117834000},"page":"3352-3361","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":272,"title":["Targetable kinase gene fusions in high-risk B-ALL: a study from the Children\u2019s Oncology Group"],"prefix":"10.1182","volume":"129","author":[{"given":"Shalini C.","family":"Reshmi","sequence":"first","affiliation":[{"name":"Institute for Genomic Medicine, Nationwide Children\u2019s Hospital, Columbus, OH;"},{"name":"Department of Pathology, The Ohio State University College of Medicine, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4904-9767","authenticated-orcid":false,"given":"Richard C.","family":"Harvey","sequence":"additional","affiliation":[{"name":"University of New Mexico Cancer Center, Albuquerque, NM;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn G.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen","family":"Stonerock","sequence":"additional","affiliation":[{"name":"Institute for Genomic Medicine, Nationwide Children\u2019s Hospital, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Smith","sequence":"additional","affiliation":[{"name":"Comprehensive Cancer Center, The Ohio State University College of Medicine, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Jenkins","sequence":"additional","affiliation":[{"name":"Institute for Genomic Medicine, Nationwide Children\u2019s Hospital, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"University of New Mexico Cancer Center, Albuquerque, NM;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Valentine","sequence":"additional","affiliation":[{"name":"Department of Cytogenetics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Computational Biology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Computational Biology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Easton","sequence":"additional","affiliation":[{"name":"Department of Computational Biology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Payne-Turner","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Gu","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thai Hoa","family":"Tran","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UCSF Benioff Children\u2019s Hospital and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan V.","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UCSF Benioff Children\u2019s Hospital and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi","family":"Devidas","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Florida, Gainesville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfeng","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, University of Florida, Gainesville, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyla A.","family":"Heerema","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Ohio State University College of Medicine, Columbus, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Andrew J.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Department of Genetics, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Raetz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Borowitz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University, Baltimore, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent L.","family":"Wood","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Hospital, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Angiolillo","sequence":"additional","affiliation":[{"name":"Children\u2019s National Medical Center, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Burke","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanda L.","family":"Salzer","sequence":"additional","affiliation":[{"name":"US Army Medical Research and Materiel Command, Fort Detrick, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Zweidler-McKay","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, MD Anderson Cancer Center, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen R.","family":"Rabin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L.","family":"Carroll","sequence":"additional","affiliation":[{"name":"Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Computational Biology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mignon L.","family":"Loh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, UCSF Benioff Children\u2019s Hospital and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles G.","family":"Mullighan","sequence":"additional","affiliation":[{"name":"Department of Pathology, St. Jude Children\u2019s Research Hospital, Memphis, TN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L.","family":"Willman","sequence":"additional","affiliation":[{"name":"University of New Mexico Cancer Center, Albuquerque, NM;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Gastier-Foster","sequence":"additional","affiliation":[{"name":"Institute for Genomic Medicine, Nationwide Children\u2019s Hospital, Columbus, OH;"},{"name":"Department of Pathology, The Ohio State University College of Medicine, Columbus, OH;"},{"name":"Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Hunger","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"26","key":"2019111900182573800_B1","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1182\/blood-2015-02-580043","article-title":"Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine","volume":"125","author":"Hunger","year":"2015","journal-title":"Blood"},{"issue":"27","key":"2019111900182573800_B2","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1200\/JCO.2014.59.1636","article-title":"Childhood acute lymphoblastic leukemia: progress through collaboration","volume":"33","author":"Pui","year":"2015","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111900182573800_B3","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1182\/blood-2014-03-562918","article-title":"A novel integrated cytogenetic and genomic classification refines risk stratification in pediatric acute lymphoblastic leukemia","volume":"124","author":"Moorman","year":"2014","journal-title":"Blood"},{"issue":"2","key":"2019111900182573800_B4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study","volume":"10","author":"Den Boer","year":"2009","journal-title":"Lancet Oncol"},{"issue":"5","key":"2019111900182573800_B5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111900182573800_B6","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"23","key":"2019111900182573800_B7","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111900182573800_B8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.blre.2016.09.001","article-title":"BCR-ABL (Ph)-like acute leukemia-Pathogenesis, diagnosis and therapeutic options","volume":"31","author":"Ofran","year":"2017","journal-title":"Blood Rev"},{"issue":"26","key":"2019111900182573800_B9","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic\/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2019111900182573800_B10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2012-04-422691","article-title":"Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group TARGET project","volume":"121","author":"Loh","year":"2013","journal-title":"Blood"},{"issue":"4","key":"2019111900182573800_B11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High frequency and poor outcome of Philadelphia chromosome-like acute lymphoblastic leukemia in adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J Clin Oncol"},{"issue":"15","key":"2019111900182573800_B12","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent prognostic value of BCR-ABL1-like signature and IKZF1 deletion, but not high CRLF2 expression, in children with B-cell precursor ALL","volume":"122","author":"van der Veer","year":"2013","journal-title":"Blood"},{"issue":"7","key":"2019111900182573800_B13","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.3324\/haematol.2014.117424","article-title":"Expression profiling of adult acute lymphoblastic leukemia identifies a BCR-ABL1-like subgroup characterized by high non-response and relapse rates","volume":"100","author":"Boer","year":"2015","journal-title":"Haematologica"},{"issue":"2","key":"2019111900182573800_B14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccell.2015.12.013","article-title":"Truncating erythropoietin receptor rearrangements in acute lymphoblastic leukemia","volume":"29","author":"Iacobucci","year":"2016","journal-title":"Cancer Cell"},{"issue":"2","key":"2019111900182573800_B15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ccr.2012.06.005","article-title":"Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia","volume":"22","author":"Roberts","year":"2012","journal-title":"Cancer Cell"},{"issue":"18","key":"2019111900182573800_B16","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2015-09-670166","article-title":"EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications","volume":"127","author":"Schwab","year":"2016","journal-title":"Blood"},{"issue":"11","key":"2019111900182573800_B17","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/blood-2011-03-341412","article-title":"Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children\u2019s Oncology Group","volume":"118","author":"Zhang","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111900182573800_B18","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/ng.469","article-title":"Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia","volume":"41","author":"Mullighan","year":"2009","journal-title":"Nat Genet"},{"issue":"26","key":"2019111900182573800_B19","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood"},{"issue":"13","key":"2019111900182573800_B20","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"issue":"14","key":"2019111900182573800_B21","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2013.51.3242","article-title":"IGH@ translocations are prevalent in teenagers and young adults with acute lymphoblastic leukemia and are associated with a poor outcome","volume":"32","author":"Russell","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111900182573800_B22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2012.09221.x","article-title":"Treatment outcome of CRLF2-rearranged childhood acute lymphoblastic leukaemia: a comparative analysis of the AIEOP-BFM and UK NCRI-CCLG study groups","volume":"158","author":"Attarbaschi","year":"2012","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111900182573800_B23","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1182\/blood-2009-08-235408","article-title":"Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group","volume":"115","author":"Hertzberg","year":"2010","journal-title":"Blood"},{"issue":"9648","key":"2019111900182573800_B24","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(08)61341-0","article-title":"Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down\u2019s syndrome","volume":"372","author":"Bercovich","year":"2008","journal-title":"Lancet"},{"issue":"17","key":"2019111900182573800_B25","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1182\/blood-2012-03-415448","article-title":"Targeting JAK1\/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia","volume":"120","author":"Maude","year":"2012","journal-title":"Blood"},{"issue":"23","key":"2019111900182573800_B26","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111900182573800_B27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/leu.2008.250","article-title":"A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin","volume":"23","author":"Russell","year":"2009","journal-title":"Leukemia"},{"issue":"25","key":"2019111900182573800_B28","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1200\/JCO.2012.47.6770","article-title":"Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia","volume":"31","author":"Weston","year":"2013","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111900182573800_B29","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","article-title":"Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis","volume":"363","author":"Verstovsek","year":"2010","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111900182573800_B30","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/pbc.25327","article-title":"TKI dasatinib monotherapy for a patient with Ph-like ALL bearing ATF7IP\/PDGFRB translocation","volume":"62","author":"Kobayashi","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2019111900182573800_B31","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bjh.13757","article-title":"Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion","volume":"171","author":"Yano","year":"2015","journal-title":"Br J Haematol"},{"issue":"9","key":"2019111900182573800_B32","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.3324\/haematol.2015.124941","article-title":"BCR-ABL1-like cases in pediatric acute lymphoblastic leukemia: a comparison between DCOG\/Erasmus MC and COG\/St. Jude signatures","volume":"100","author":"Boer","year":"2015","journal-title":"Haematologica"},{"issue":"8","key":"2019111900182573800_B33","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1182\/blood-2014-04-570960","article-title":"The role of the Janus-faced transcription factor PAX5-JAK2 in acute lymphoblastic leukemia","volume":"125","author":"Schinnerl","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2019111900182573800_B34","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children\u2019s Oncology Group study","volume":"111","author":"Borowitz","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2019111900182573800_B35","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1182\/blood-2015-03-633685","article-title":"Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children\u2019s Oncology Group study AALL0232","volume":"126","author":"Borowitz","year":"2015","journal-title":"Blood"},{"issue":"10","key":"2019111900182573800_B36","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression","volume":"99","author":"Tibshirani","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"2019111900182573800_B37","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.826.826","article-title":"Development and validation of a highly sensitive and specific gene expression classifier to prospectively screen and identify B-precursor acute lymphoblastic leukemia (ALL) patients with a Philadelphia chromosome-like (\u201cPh-like\u201d or \u201cBCR-ABL1-like\u201d) signature for therapeutic targeting and clinical intervention [abstract]","volume":"122","author":"Harvey","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2019111900182573800_B38","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat Genet"},{"issue":"12","key":"2019111900182573800_B39","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/ng.3691","article-title":"Deregulation of DUX4 and ERG in acute lymphoblastic leukemia","volume":"48","author":"Zhang","year":"2016","journal-title":"Nat Genet"},{"key":"2019111900182573800_B40","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1038\/ncomms13331","article-title":"Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukemia","volume":"7","author":"Gu","year":"2016","journal-title":"Nat Commun"},{"issue":"5","key":"2019111900182573800_B41","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20110580","article-title":"Gain-of-function mutations in interleukin-7 receptor-\u03b1 (IL7R) in childhood acute lymphoblastic leukemias [published correction appears in J Exp Med. 2011;208(6):1333","volume":"208","author":"Shochat","year":"2011","journal-title":"J Exp Med"},{"issue":"7234","key":"2019111900182573800_B42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature07638","article-title":"Transcriptome sequencing to detect gene fusions in cancer","volume":"458","author":"Maher","year":"2009","journal-title":"Nature"},{"issue":"30","key":"2019111900182573800_B43","doi-asserted-by":"crossref","first-page":"12353","DOI":"10.1073\/pnas.0904720106","article-title":"Chimeric transcript discovery by paired-end transcriptome sequencing","volume":"106","author":"Maher","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111900182573800_B44","article-title":"FusionCatcher: a tool for finding somatic fusion genes in paired-end RNA-sequencing data","author":"Nicorici","journal-title":"bioRxivorg"},{"issue":"9","key":"2019111900182573800_B45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"issue":"27","key":"2019111900182573800_B46","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2014.55.4105","article-title":"Outcomes of children with BCR-ABL1\u2013like acute lymphoblastic leukemia treated with risk-directed therapy based on the levels of minimal residual disease","volume":"32","author":"Roberts","year":"2014","journal-title":"J Clin Oncol"},{"issue":"15","key":"2019111900182573800_B47","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2011-11-394221","article-title":"Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"119","author":"Chen","year":"2012","journal-title":"Blood"},{"issue":"1","key":"2019111900182573800_B48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccell.2015.06.005","article-title":"Activity of the type II JAK2 inhibitor CHZ868 in B cell acute lymphoblastic leukemia","volume":"28","author":"Wu","year":"2015","journal-title":"Cancer Cell"},{"issue":"2","key":"2019111900182573800_B49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/blood-2016-05-707653","article-title":"Potent efficacy of combined PI3K\/mTOR and JAK or ABL inhibition in murine xenograft models of Ph-like acute lymphoblastic leukemia","volume":"129","author":"Tasian","year":"2017","journal-title":"Blood"},{"issue":"31","key":"2019111900182573800_B50","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1200\/JCO.2008.21.2514","article-title":"Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children\u2019s Oncology Group study","volume":"27","author":"Schultz","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111900182573800_B51","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/leu.2014.30","article-title":"Long-term follow-up of imatinib in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia: Children\u2019s Oncology Group study AALL0031","volume":"28","author":"Schultz","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"2019111900182573800_B52","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(12)70377-7","article-title":"Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study","volume":"13","author":"Biondi","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"2019111900182573800_B53","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/leu.2009.167","article-title":"Identification of a novel TEL-Lyn fusion gene in primary myelofibrosis","volume":"24","author":"Tanaka","year":"2010","journal-title":"Leukemia"},{"key":"2019111900182573800_B54","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3389\/fonc.2014.00263","article-title":"The biology and targeting of FLT3 in pediatric leukemia","volume":"4","author":"Annesley","year":"2014","journal-title":"Front Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/25\/3352\/1364378\/blood758979.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/129\/25\/3352\/1364378\/blood758979.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:18:46Z","timestamp":1574122726000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/129\/25\/3352\/107622\/Targetable-kinase-gene-fusions-in-highrisk-BALL-a"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,22]]},"references-count":54,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2017,6,22]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-12-758979","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727506709.793551059","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,22]]}}}